Announcing Our Series B: The What, When, Why, Who, and Where

Patrick Grady
|
April 15, 2021

What and When 

We are incredibly excited and profoundly grateful to announce the closing of our $80 million Series B which was co-led by Insight Partners and Alkeon Capital. This round brings our overall funding to over $92 million since Spin and I completely reimagined and rebuilt the company less than two years ago in our quest to deliver the world’s first and only open R&D Data Cloud, in pursuit of our mission to accelerate discovery and improve and extend human life.

This massive injection of capital validates our category leadership and enables us to materially accelerate our go-to-market capabilities, expand our industry-leading technical capabilities, and grow our cross-domain team of scientific, data science, and cloud experts.

Why

Having only recently closed our 2020 Series A round and having most of that cash still on hand today, we were neither in need of capital nor were we actively seeking it. If this were most any other startup, we wouldn’t have been in favor of raising a Series B any time soon, but we ultimately chose to pursue it for the following reasons:

Our Mission

Our mission is to be the most trusted and valuable partner to the world’s scientific community, fueling innovation, facilitating collaboration, accelerating discovery, and enhancing and extending human life.

Unlike most startups, the achievement of our mission really does have life and death consequences for individuals and their families, and profound implications for humanity as a whole. To not accelerate our initiatives in furtherance of our mission would have been short-sighted and irresponsible.

Our Timing

The rise of cloud technology has been one of the most transformational innovation and growth stories in history, but its adoption has been uneven. Over the last two decades the private and public sectors have embraced the cloud to automate processes and/or organize and engineer data on a continuum – from non-core areas to increasingly core and now mission critical ones – as their trust in SaaS and cloud providers has grown.

Like our industry customers and partners, we view experimental research and development data, generated by the most advanced research labs in vital industries such as life sciences, chemicals, agricultural, materials, and energy, as the world’s most important data asset. Understandably, these industries have been reticent to move their most important intellectual property to the cloud until they had complete conviction in its underlying capabilities and their technology partners of choice.

While the benefits of cloud computing have grown unabated and likely met the risk/reward threshold for R&D labs a few years ago, COVID-19 has heightened the urgency to replatform to the cloud and take advantage of advanced data science and AI/ML as pharmaceutical companies face enormous societal, governmental, and shareholder pressure to radically accelerate discovery.

Our Metrics

The growth of 23-month-old “Tetra 2.0” places us in rare company, alongside the fastest-growing cloud startups of all time. From a standing start in May 2019, our ARR, customer acquisition costs, retention and expansion, and capital efficiency metrics are all best-in-class.

Notwithstanding how essential our mission is, or how great the market timing may be, we are informed by our metrics and they are guiding us to invest aggressively in our business to fully capitalize on this generational replatforming opportunity.

Who

While we weren’t actively seeking capital, I fielded inbound calls and spent time with nearly 20 funds over the past 5 months. I applied four criteria in evaluating potential financial partners – domain expertise, multi-stage investment capabilities, partner experience, and vision alignment.

Simply put, we wanted to partner with 1-2 funds for the long journey ahead and weren’t looking to simply optimize Series B terms. We wanted strategic financial partners who were informed, patient, mature, and supportive of our category vision. In the final analysis, while we had interest from some terrific partners at renowned funds, given our criteria, Insight and Alkeon were the clear choices for us.  

Insight Partners, a leading global $30 billion venture and growth equity fund, brought to bear highly relevant investment experiences across our key domains of biopharma and cloud and a well-developed industry thesis which was consistent with our own. They also put forth a large and well-informed deal team, led by two GPs – Deven Parekh and Nikhil Sachdev – and were as efficient as any CEO could hope for in raising capital. We’re excited to announce that Deven will be joining our board while Nikhil will remain an active and trusted partner to me.

Alkeon Capital, a leading global $30 billion hedge fund and growth equity fund, also brought highly relevant experience in biopharma, cloud, and AI to the table. Leveraging insights derived from their significant biotech portfolio, as well as their investment in Benchling’s 2020 growth round, Alkeon immediately understood the market need for the Tetra R&D Data platform and the markers of a category leader in all we were building. Abhi Arun, our GP from Alkeon, has quickly emerged as a value-added partner to me and I’m excited to collaborate with him as we scale the company and build this transformational R&D Data Cloud movement.

Where to Now

From a standing start in May 2019 to a multi-hundred million dollar valuation and a fortress balance sheet of tens of millions in only 23 months is something to be proud of, but we are far more proud of the culture we’ve created to achieve this milestone and enable us to deliver for all of our stakeholders.

Notwithstanding the scale and velocity of our Series A and B rounds, everyone on Team Tetra knows that we are just getting started as we build a company of uncommon value and profound societal consequence.

Thank you to all who have believed in us these past 23 months.

Patrick and Spin

Share this article

Previous post

There is no previous post
Back to all posts
May 18, 2022

Tetra Blasts Off at Boston’s Bio-IT World

Read Blog
May 9, 2022

Give Your in vivo Data the Attention it Deserves

Read Blog
May 2, 2022

Customizing Digital Lab Experiences With Ease

Read Blog
April 14, 2022

Sharing a Vision and Deep Customer Commitment

Read Blog
April 11, 2022

Escaping the Scientific Data Quagmire

Read Blog
April 1, 2022

Innovating with a HoloLens and Drones

Read Blog
April 6, 2022

Digital Twins: Seeing Double with a Predictive Eye

Read Blog
March 28, 2022

Automated Anomaly Detection and Correction

Read Blog
March 30, 2022

Making Labs More Efficient

Read Blog
March 4, 2022

Introducing Tetra Data Platform v3.2

Read Blog
March 2, 2022

Are you prepared to utilize ML/AI and Data Visualization?

Read Blog
February 22, 2022

SLAS 2022: The Industry’s “Hyped” for Accessible and Actionable Scientific Data

Read Blog
February 21, 2022

BIOVIA partners with TetraScience

Read Blog
February 16, 2022

Tetra Partner Network: An Interview with Klemen Zupancic, CEO, SciNote

Read Blog
February 4, 2022

Closing the Data Gap in Cancer Research

Read Blog
January 27, 2022

Waters & The Tetra Partner Network: Making Data Science Possible

Read Blog
December 16, 2021

Announcing Acquisition of Tetra Lab Monitoring Business by Elemental Machines

Read Blog
November 29, 2021

Move From Fractal to Flywheel with The Tetra Partner Network

Read Blog
March 26, 2021

How an IDS Complements Raw Experimental R&D Data in the Digital Lab

Read Blog
July 30, 2021

What is an R&D Data Cloud? (And Why Should You Care?)

Read Blog
March 26, 2021

What is a True Data Integration, Anyway?

Read Blog
June 1, 2020

Data Science Use Cases for the Digital Lab: Novel Analyses with Waters Empower CDS Data

Read Blog
April 20, 2022

Unlock the Power of Your ELN and LIMS

Read Blog
July 23, 2020

The Science Behind Trash Data

Read Blog
August 20, 2021

The 4 Keys to Unlock the Lab of the Future

Read Blog
September 29, 2021

TetraScience Achieves SOC 2 Type 2 Validation, Advances R&D Data Cloud GxP Compliance Capabilities

Read Blog
April 20, 2020

Round-up of Semantic Web thought leadership articles

Read Blog
September 19, 2020

Simplified Remote Monitoring of CO₂ Incubators via Direct Integration

Read Blog
May 11, 2021

R&D Data Cloud: Moving Your Digital Lab Beyond SDMS

Read Blog
September 10, 2021

Principles of Deep Learning Theory

Read Blog
July 8, 2020

Powering Bioprocessing 4.0 for Therapeutic Development

Read Blog
March 30, 2022

Why Biopharma Needs an End-to-End, Purpose-Built Platform for Scientific Data — Part 2

Read Blog
August 19, 2021

Part 2: How TetraScience Approaches the Challenge of Scaling True Scientific Data Integrations

Read Blog
March 23, 2022

Why Biopharma Needs an End-to-End, Purpose-Built Platform for Scientific Data — Part 1

Read Blog
January 18, 2021

New Matter: Inside the Minds of SLAS Scientists Podcast

Read Blog
June 29, 2020

Enabling Compliance in GxP Labs

Read Blog
May 14, 2020

LRIG-New England: Lunchtime Virtual Rapid Fire Event - May 26, 2020

Read Blog
June 10, 2020

Remote Lab Scheduling is No Longer Optional, it is a Requirement

Read Blog
August 2, 2020

Incident Reporting for GxP Compliance

Read Blog
October 15, 2020

Protein Purification with Cytiva UNICORN: Enhanced Analytics through Harmonization and Integration

Read Blog
July 29, 2020

Cloud-based Data Management with Lab Automation: HighRes Biosolutions Cellario + TetraScience

Read Blog
August 20, 2020

Understanding Why Freezer Temperatures May Not Be Uniform

Read Blog
July 14, 2021

Find Experimental Data Faster with Google-Like Search in Tetra Data Platform 3.1 Release

Read Blog
July 22, 2021

Experimental Data in Life Sciences R&D — It’s How Many Copies of Jaws?!

Read Blog
July 15, 2020

Direct Data Acquisition and Sensor Integration for ThermoFisher Heracell™ VIOS CO₂ Incubators

Read Blog
September 15, 2020

Remote Monitoring of VWR CO₂ Incubators via Direct Integration

Read Blog
April 26, 2020

The Digital Lab Needs an Intermediate Data Schema (IDS): a First Principle Analysis

Read Blog
April 6, 2020

TetraScience ADF Converter -- Delivering on the Promise of Allotrope and a Startup’s Journey

Read Blog
August 6, 2020

"Data Plumbing" for the Digital Lab

Read Blog
June 8, 2020

Data Automation for High-Throughput Screening with Dotmatics, Tecan, and PerkinElmer Envision

Read Blog
May 15, 2020

Applying Data Automation and Standards to Cell Counter Files

Read Blog
June 11, 2020

AWS Healthcare & Life Sciences Web Day | Virtual Industry Event

Read Blog
February 12, 2021

AWS Executive Conversations: Evolving R&D

Read Blog
April 15, 2021

Announcing Our Series B: The What, When, Why, Who, and Where

Read Blog
April 15, 2021

Announcing our Series B: The DNA Markers of Category Kings and Queens

Read Blog
April 15, 2021

Announcing our Series B: Tetra 1.0 and 2.0 | The Noise and the Signal

Read Blog
March 29, 2020

Allotrope Leaf Node Model — a Balance between Practical Solution and Semantics Compatibility

Read Blog
April 3, 2019

Allotrope 101

Read Blog
March 13, 2020

Choose the right alert set points for your freezers, refrigerators, and incubators

Read Blog
August 27, 2020

99 Problems, but an SDMS Ain't One

Read Blog